Should you buy CLCS stock?
Last updated:
Based on market data through , StockInvest.us rates Cell Source, Inc. (CLCS) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Hold signal since
- Price since signal Flat 0.00%
- 3-month trend forecast Down 12.38%
- Easy Tracking In The Watchlist
Red day on Monday for Cell Source, Inc. stock after losing 0%
(Market data through Aug 10, 2026)
No changes to the price of Cell Source, Inc. stock on the last trading day (Monday, 10th Aug 2026). During the last trading day the stock fluctuated 0% from a day low at $0.719 to a day high of $0.719. The price has been going up and down for this period, and there has been a -14.5% loss for the last 2 weeks.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.38% during the next 3 months and, with a 90% probability hold a price between $0.492 and $0.794 at the end of this 3-month period.
CLCS Signals & Forecast
There are mixed signals in the stock today. The Cell Source, Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.766. On a fall, the stock will find some support from the short-term average at $0.657. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, August 07, 2026, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for Cell Source, Inc. stock
On the downside, the stock finds support just below today's level from accumulated volume at $0.655 and $0.645. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Cell Source, Inc. finds support just below today's level at $0.655. If this is broken, then the next support from accumulated volume will be at $0.645 and $0.640.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 5.41%
Our recommended stop-loss: $0.690 (-4.10%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (CLCS) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Cell Source, Inc. to open at $0.719, and during the day (based on 14 day Average True Range), to move between $0.683 and $0.755, which gives a possible trading interval of +/-$0.0725 (+/-10.62%) up or down from last closing price. If Cell Source, Inc. takes out the full calculated possible swing range there will be an estimated 10.62% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $0.782 (8.79%) than the support at $0.655 (8.97%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Cell Source, Inc. stock A Buy?
Cell Source, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
0.000
Hold/Accumulate
Unchanged
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $0.719 ( 0%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
CLCS Performance
Trading levels for CLCS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.719 | - |
| R2 | 0.719 | - |
| R1 | 0.719 | - |
| Price | 0.719 | |
| S1 | 0.719 | - |
| S2 | 0.719 | - |
| S3 | 0.719 | - |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.84 | 16.83% |
| R2 | 0.80 | 11.27% |
| R1 | 0.782 | 8.79% |
| Price | 0.719 | |
| S1 | 0.655 | -8.97% |
| S2 | 0.645 | -10.29% |
| S3 | 0.640 | -10.99% |
FAQ
Click here for our free guide on how to buy Cell Source, Inc. Stock.
Buy CLCS
A sell signal from a double top formation was found on Monday, June 29, 2026 with a target of $0.723. Despite whether the objective of the signal formation has been reached the stock may continue to fall.